DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Cytomegalovirus Infection - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Cytomegalovirus Infection (49)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neoral (Cyclosporine) where reactions include cytomegalovirus infection. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 49   Next >>

Possible Neoral side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Pneumonia Aspiration, Unresponsive To Stimuli, Wound, Herpes Simplex, Oedema Peripheral, Pulmonary Oedema, Apnoea, Cardiac Failure Congestive, Metabolic Acidosis, Malnutrition, Convulsion, Sepsis Syndrome, Fungal Infection, Ventricular Tachycardia, Depressed Level of Consciousness, Metabolic Encephalopathy, Confusional State, Brachiocephalic Vein Stenosis, Somnolence, Cytomegalovirus Gastritis, Multi-Organ Failure, Hearing Impaired, Acute Respiratory Failure, Sinusitis, Renal Failure Acute, Pneumonia Fungal, Dyspnoea, Hyponatraemia, Mental Impairment, Pneumonia Herpes Viral, Cytomegalovirus Infection, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Darbepoetin Alfa; Heparin; Atrovent; Metoprolol Tartrate; Lasix; Zyvox; Imodium; Acyclovir; Cefepime; Allopurinol; Bumex; Albuterol; Amlodipine; Micafungin; Gabapentin; Entecavir; Prednisolone; Pantoprazole; Insulin; Morphine; Prednisolone; Urea; Lovenox



Possible Neoral side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-13

Patient: 59 year old male

Reactions: Respiratory Disorder, Hallucination, Auditory, Motor Dysfunction, Acute Myeloid Leukaemia, Encephalopathy, Pyrexia, Parkinsonism, Cerebral Toxoplasmosis, Pneumonia Cytomegaloviral, Agnosia, Micturition Disorder, Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Memory Impairment, Altered State of Consciousness, Frustration

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Methotrexate; Ganciclovir; Fludarabine Phosphate; Melphalan Hydrochloride



Possible Neoral side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-30

Patient: 64 year old male

Reactions: Interstitial Lung Disease, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cyclophosphamide



Possible Neoral side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27

Patient: 64 year old male

Reactions: Interstitial Lung Disease, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cyclophosphamide



Possible Neoral side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-27

Patient: 64 year old male

Reactions: Interstitial Lung Disease, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Cyclophosphamide



Possible Neoral side effects in male

Reported by a physician from France on 2012-07-25

Patient: male, weighing 85.0 kg (187.0 pounds)

Reactions: Hydrocele Male Infected, Pyelonephritis Acute, Cytomegalovirus Infection, Renal Failure Acute, Infected Lymphocele

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mycophenolic Acid
    Dosage: 350 mg, bid
    Administration route: Oral
    Start date: 2011-04-29

Prednisone
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2010-08-17

Mycophenolic Acid
    Dosage: 720 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-12
    End date: 2011-04-25

Neoral
    Dosage: 75 mg, bid
    Administration route: Oral
    Start date: 2010-09-14

Neoral
    Dosage: 150 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-08-13
    End date: 2010-09-13

Other drugs received by patient: Prednisolone; Eupressyl; Atenolol; Hyperium



Possible Neoral side effects in male

Reported by a physician from Mexico on 2012-07-13

Patient: male, weighing 48.0 kg (105.6 pounds)

Reactions: Jaundice, Gastrointestinal Haemorrhage, Pneumonia, Complications of Transplanted Kidney, Respiratory Failure, Cytomegalovirus Infection, Acute Respiratory Distress Syndrome, Gastritis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 25 mg, bid
    Administration route: Oral
    End date: 2012-06-13

Neoral
    Dosage: 25 mg, bid
    Administration route: Oral
    Start date: 2012-06-18

Prednisone
    Dosage: 15 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-05-16
    End date: 2012-06-13

Neoral
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2012-05-02

Prednisone
    Dosage: 15 mg, qd
    Administration route: Oral

Other drugs received by patient: Acyclovir; Myfortic; Bactrim; Amlodipine; Myfortic; Nystatin; Metoprolol Tartrate; Losartan Potassium



Possible Neoral side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-09

Patient: male, weighing 64.0 kg (140.8 pounds)

Reactions: Hepatitis B Antibody Positive, Epstein-Barr Virus Infection, Post Transplant Lymphoproliferative Disorder, Primary Mediastinal Large B-Cell Lymphoma, Cytomegalovirus Test Positive, Blood Uric Acid Increased, Cytomegalovirus Infection, Pyrexia, Hepatic Neoplasm

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Simulect
    Dosage: 20 mg, once/single
    Start date: 2007-05-20
    End date: 2007-05-20

Cellcept
    Dosage: 1500 mg/day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-05-17

Neoral
    Dosage: 500 mg/day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-05-13
    End date: 2007-05-23

Simulect
    Dosage: 20 mg, once/single
    Indication: Renal Transplant
    Start date: 2007-05-16
    End date: 2007-05-16

Other drugs received by patient: Sandimmune; Cinalong; Diovan; Solu-Medrol; Zyloric ^fresenius^; Prednisolone; Prednisolone; Allopurinol



Possible Neoral side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-23

Patient: 52 year old female

Reactions: White Blood Cell Count Decreased, Hepatic Function Abnormal, Drug Ineffective, Hepatic Failure, Pancytopenia, Pyrexia, Oropharyngeal Pain, Herpes Zoster, Epstein-Barr Virus Infection, Fatigue, Pharyngeal Oedema, Hepatic Encephalopathy, Herpes Simplex, Peliosis Hepatis, Acute Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Hepatitis B

Adverse event resulted in: death

Drug(s) suspected as cause:
ATG-Fresenius
    Dosage: unk ukn, unk

Thymoglobulin
    Dosage: 2.5 mg/kg, per day

Metenolone Acetate
    Dosage: unk ukn, unk

Immune Globulin (Human)
    Dosage: unk ukn, unk

Neoral
    Dosage: 130 mg, daily
    Administration route: Oral
    Start date: 2009-01-14
    End date: 2009-05-02

Neoral
    Dosage: 3 mg/kg, per day
    Indication: Bone Marrow Transplant

Thymoglobulin
    Dosage: 110 mg daily
    Start date: 2009-01-09
    End date: 2009-01-12

Other drugs received by patient: Methotrexate; Acyclovir; Platelets; Levofloxacin; Acyclovir; Moxifloxacin; RED Blood Cells; Methotrexate; Fludarabine Phosphate; Cytoxan; Filgrastim; Fluconazole; Acyclovir; Pentamidine Isethionate



Possible Neoral side effects in 52 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-22

Patient: 52 year old female

Reactions: White Blood Cell Count Decreased, Hepatic Function Abnormal, Drug Ineffective, Hepatic Failure, Pancytopenia, Oropharyngeal Pain, Pyrexia, Herpes Zoster, Epstein-Barr Virus Infection, Pharyngeal Oedema, Fatigue, Hepatic Encephalopathy, Herpes Simplex, Peliosis Hepatis, Acute Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Hepatitis B

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral
    Dosage: 130 mg, daily
    Administration route: Oral
    Start date: 2009-01-14
    End date: 2009-05-02

Thymoglobulin
    Dosage: 2.5 mg/kg, per day

Immune Globulin (Human)
    Dosage: unk ukn, unk

ATG-Fresenius
    Dosage: unk ukn, unk

Thymoglobulin
    Dosage: 110 mg daily
    Start date: 2009-01-09
    End date: 2009-01-12

Neoral
    Dosage: 3 mg/kg, per day
    Indication: Bone Marrow Transplant

Metenolone Acetate
    Dosage: unk ukn, unk

Other drugs received by patient: Cyclophosphamide; Pentamidine Isethionate; Acyclovir; Moxifloxacin; RED Blood Cells; Fludarabine Phosphate; Methotrexate; Acyclovir; Methotrexate; Levofloxacin; Fluconazole; Acyclovir; Filgrastim; Platelets



Possible Neoral side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-18

Patient: 37 year old female

Reactions: Subdural Haematoma, Hepatic Function Abnormal, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Acute Graft Versus Host Disease in Skin, Cytomegalovirus Infection, Chronic Graft Versus Host Disease

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk ukn, unk
    Start date: 2009-05-16
    End date: 2009-05-22

Gleevec
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2009-06-30

Methotrexate
    Dosage: 15 mg/m2, unk

Methotrexate
    Dosage: 10 mg/m2, unk

Neoral
    Dosage: 80 mg, unk
    Administration route: Oral

Neoral
    Dosage: 120 mg, unk
    Administration route: Oral
    Start date: 2010-01-01

Idarubicin Hydrochloride
    Dosage: unk ukn, unk
    Start date: 2009-05-16
    End date: 2009-05-18

Neoral
    Dosage: 60 mg, unk
    Administration route: Oral

Gleevec
    Dosage: 600 mg, daily
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia Transformation
    Start date: 2009-05-23
    End date: 2009-06-16

Methotrexate
    Dosage: 10 mg/m2, unk

Other drugs received by patient: Prednisolone



Possible Neoral side effects in 37 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-15

Patient: 37 year old female

Reactions: Subdural Haematoma, Hepatic Function Abnormal, Acute Graft Versus Host Disease in Skin, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Cytomegalovirus Infection, Chronic Graft Versus Host Disease

Drug(s) suspected as cause:
Gleevec
    Dosage: unk ukn, unk
    Administration route: Oral
    Start date: 2009-06-30

Gleevec
    Dosage: 600 mg, daily
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia Transformation
    Start date: 2009-05-23
    End date: 2009-06-16

Neoral
    Dosage: 80 mg, unk
    Administration route: Oral

Idarubicin Hydrochloride
    Dosage: unk ukn, unk
    Start date: 2009-05-16
    End date: 2009-05-18

Methotrexate
    Dosage: 15 mg/m2, unk

Neoral
    Dosage: 60 mg, unk
    Administration route: Oral

Methotrexate
    Dosage: 10 mg/m2, unk

Methotrexate
    Dosage: 10 mg/m2, unk

Neoral
    Dosage: 120 mg, unk
    Administration route: Oral
    Start date: 2010-01-01

Cytarabine
    Dosage: unk ukn, unk
    Start date: 2009-05-16
    End date: 2009-05-22

Other drugs received by patient: Prednisolone



Possible Neoral side effects in

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-14

Patient:

Reactions: Respiratory Failure, Cytomegalovirus Infection, Meningitis Viral

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Basiliximab; Corticosteroids



Possible Neoral side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-09

Patient: 50 year old male

Reactions: Guillain-Barre Syndrome, Dyspnoea, Dysphagia, Acute Graft Versus Host Disease, Muscular Weakness, Paralysis, Pyrexia, Nerve Conduction Studies Abnormal, Neuropathy Peripheral, Dysphonia, Diarrhoea, Sensory Disturbance, Cytomegalovirus Infection, Areflexia, Erythema Multiforme

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 200 mg, daily
    Administration route: Oral
    Indication: Allogenic Bone Marrow Transplantation Therapy

Sandimmune
    Dosage: 4 mg/kg, daily
    Indication: Allogenic Bone Marrow Transplantation Therapy

Other drugs received by patient: Prednisolone



Possible Neoral side effects in 40 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-30

Patient: 40 year old female

Reactions: Abdominal Pain, Blood Urea Increased, Blood Potassium Increased, Pancytopenia, Idiopathic Thrombocytopenic Purpura, Renal Failure, Immunoglobulins Decreased, Systemic Lupus Erythematosus, Thrombocytosis, Cytomegalovirus Infection, Platelet Count Decreased, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Valganciclovir
    Dosage: 240 mg, unk
    Administration route: Oral
    Indication: Cytomegalovirus Infection
    Start date: 2010-02-01

Adrenal Cortical Extract
    Dosage: 15 mg, unk
    Administration route: Oral
    Indication: Systemic Lupus Erythematosus
    Start date: 2009-10-01

Neoral
    Dosage: 125 mg daily
    Administration route: Oral
    Indication: Systemic Lupus Erythematosus
    Start date: 2009-10-01
    End date: 2010-02-01

Other drugs received by patient: Immune Globulin (Human); Immune Globulin (Human); Steroids NOS



Possible Neoral side effects in male

Reported by a physician from France on 2012-04-20

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Bronchial Obstruction, Klebsiella Infection, Thrombocytopenia, Post Procedural Haemorrhage, Escherichia Sepsis, Renal Vessel Disorder, Complications of Transplanted Kidney, Wound Dehiscence, Anaemia, Malnutrition, Anastomotic Haemorrhage, Wound Complication, Renal Impairment, Diarrhoea, Cytomegalovirus Infection, Renal Tubular Necrosis, Pneumonia Escherichia, Asthenia, Leukopenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-02-10

Mycophenolate Mofetil (Cellcept)
    Dosage: 1 g, per day
    Administration route: Oral
    Start date: 2011-03-01
    End date: 2011-03-08

Bactrim
    Dosage: 400 mg, per day
    Administration route: Oral
    Start date: 2011-01-24
    End date: 2011-02-01

RAD 666 / RAD 001a
    Dosage: 3 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-02-02
    End date: 2011-02-09

Neoral
    Dosage: 100 mg, qd
    Administration route: Oral
    Start date: 2011-02-27
    End date: 2011-03-16

Neoral
    Dosage: unk

Mycophenolate Mofetil (Cellcept)
    Dosage: 2 g, per day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-15
    End date: 2011-02-09

Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-17
    End date: 2011-02-01

Prednisone TAB
    Dosage: 40 mg, per day
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-01-16

Zantac
    Dosage: 150 mg, per day
    Administration route: Oral
    Start date: 2011-02-02

Valganciclovir
    Dosage: 250 mg, 9qd
    Administration route: Oral
    Start date: 2011-01-29
    End date: 2011-02-01

Nexium
    Dosage: 40 mg, per day
    Administration route: Oral
    Start date: 2011-01-16
    End date: 2011-02-01

Other drugs received by patient: Solu-Medrol; Lasix; Adancor; Esomeprazole Magnesium; Calcidia; Pantoprazole; Aspirin; Sodium Bicarbonate; Amlodipine Besylate; Econazole Nitrate; Amoxicillin; Imodium; Simulect; Eprex; Insulatard NPH Human; Potassium Chloride; Nitroderm; Mirtazapine; Aluminum Hydroxide and Magnesium Trisilicate; Alfuzosin HCL; Cotrim



Possible Neoral side effects in female

Reported by a physician from Japan on 2012-04-19

Patient: female, weighing 57.0 kg (125.4 pounds)

Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Pyrexia, Rash, Kidney Transplant Rejection, Urine Abnormality, Hypokinesia, Renal Impairment, Cytomegalovirus Infection, Pneumonia Staphylococcal

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Simulect
    Dosage: 20 mg, once/single
    Indication: Renal Transplant
    Start date: 2010-01-20
    End date: 2010-01-20

Rituxan
    Dosage: 200 mg, unk
    Start date: 2010-05-25

Mycophenolate Mofetil (Cellcept)
    Dosage: 1800 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-01-06
    End date: 2010-01-19

Mycophenolate Mofetil (Cellcept)
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2010-01-24

Mycophenolate Mofetil (Cellcept)
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2010-01-21

Neoral
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-01-17
    End date: 2010-01-19

Neoral
    Dosage: 200 mg
    Administration route: Oral
    Start date: 2010-03-02
    End date: 2010-10-03

Neoral
    Dosage: 150 mg, unk
    Administration route: Oral
    Start date: 2010-10-04

Prednisolone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2010-01-24
    End date: 2010-01-25

Prednisolone
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2010-01-29
    End date: 2010-01-30

Simulect
    Dosage: 20 mg, once/single
    Start date: 2010-01-24
    End date: 2010-01-24

Neoral
    Dosage: 300 mg, qd
    Start date: 2010-01-23
    End date: 2010-02-06

Neoral
    Dosage: 150 mg, unk
    Start date: 2011-01-24
    End date: 2011-10-12

Neoral
    Dosage: 250 mg, qd
    Administration route: Oral
    Start date: 2010-02-07
    End date: 2010-03-01

Neoral
    Dosage: 100 mg, unk
    Start date: 2011-10-13

Sandimmune
    Dosage: 100 mg, unk
    Indication: Renal Transplant
    Start date: 2010-01-20
    End date: 2010-01-22

Prednisolone
    Dosage: 30 mg, unk
    Administration route: Oral
    Start date: 2010-01-26
    End date: 2010-01-28

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2010-01-31

Rituxan
    Dosage: 200 mg, unk
    Indication: Kidney Transplant Rejection
    Start date: 2010-01-13
    End date: 2010-01-13

Other drugs received by patient: Spanidin; Solu-Medrol; Adalat CC; Adalat; Solu-Medrol



Possible Neoral side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-20

Patient: 67 year old female

Reactions: Atelectasis, Lymphadenopathy, Corneal Perforation, Conjunctivitis, Glossitis, Forced Expiratory Volume Decreased, Ulcerative Keratitis, Obliterative Bronchiolitis, Erythema, Alternaria Infection, Skin Ulcer, Lymphocytic Lymphoma, Bronchial Wall Thickening, Bronchospasm, Blister, Stomatitis, Dyspnoea, Pneumonia, Subcutaneous Abscess, Pain of Skin, Rash, Respiratory Distress, Renal Impairment, Respiratory Failure, Fungal Skin Infection, Cytomegalovirus Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Prednisolone; Prednisolone



Possible Neoral side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-15

Patient: male

Reactions: Cardio-Respiratory Arrest, Pneumonia, Diarrhoea, Sepsis, Cytomegalovirus Infection, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-06-05
    End date: 2011-11-07

Mycophenolate Mofetil (Cellcept)
    Dosage: unk
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-10-24

Other drugs received by patient: Folvite; Arkamin; Sodium Bicarbonate; Dilzem; Deflazacort; Pantocid (Pantoprazole Sodium); Azathioprine; Calcium Gluconate; Atenolol; Pantoprazole; Racecadotril



Possible Neoral side effects in male

Reported by a consumer/non-health professional from United States on 2012-03-15

Patient: male

Reactions: Cardio-Respiratory Arrest, Pneumonia, Diarrhoea, Sepsis, Cytomegalovirus Infection, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 75 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-06-05
    End date: 2011-11-07

Mycophenolate Mofetil (Cellcept)
    Dosage: unk
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-10-24

Other drugs received by patient: Folvite; Atenolol; Racecadotril; Sodium Bicarbonate; Dilzem; Calcium Gluconate; Deflazacort; Arkamin; Azathioprine; Pantoprazole; Pantocid (Pantoprazole Sodium)



Possible Neoral side effects in 60 year old male

Reported by a physician from France on 2012-03-12

Patient: 60 year old male

Reactions: BK Virus Infection, Cytomegalovirus Infection, Pseudomembranous Colitis, Epstein-Barr Viraemia, Lymphoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Myfortic
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2011-03-01
    End date: 2011-06-01

Mabcampath
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-07-29
    End date: 2011-08-01

Certican

Neoral
    Administration route: Oral
    Indication: Immunosuppression
    Start date: 2011-03-01
    End date: 2011-06-01

Mabthera
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-01

Certican
    Dosage: dose decreased
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-01
    End date: 2011-08-01

Mabcampath
    Start date: 2011-08-11

Prograf
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Neoral side effects in male

Reported by a physician from Belgium on 2012-03-08

Patient: male, weighing 68.0 kg (149.6 pounds)

Reactions: Pneumonia, Drug Level Increased, Diarrhoea, Dehydration, Duodenal Ulcer, Cytomegalovirus Infection, Neurological Symptom, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Digoxin
    Dosage: unspecified

Medrol
    Administration route: Oral
    Start date: 1995-09-17

Neoral
    Administration route: Oral
    Start date: 1995-08-08



Possible Neoral side effects in male

Reported by a physician from United States on 2012-03-08

Patient: male, weighing 83.0 kg (182.6 pounds)

Reactions: Abdominal Discomfort, Postoperative Wound Complication, Ileus, Cytomegalovirus Infection, Pyrexia, Lethargy, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Ganciclovir; Prednisone TAB; Azathioprine



Possible Neoral side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: 60 year old male

Reactions: Graft Versus Host Disease, Tuberculosis, Pseudomembranous Colitis, Cytomegalovirus Infection, Epstein-Barr Viraemia, Pancytopenia, Lymphoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, qd
    Indication: Immunosuppression

Myfortic
    Indication: Immunosuppression

Certican
    Dosage: 0.25 mg, bid
    Administration route: Oral

Mabthera
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-01
    End date: 2011-07-01

Mabthera
    Dosage: unk

Neoral
    Dosage: 160 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-03-01
    End date: 2011-06-01

Prograf
    Dosage: unk
    Indication: Graft Versus Host Disease in Skin

Campath
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-29
    End date: 2011-08-01

Campath
    Dosage: unk
    Start date: 2011-08-11

Certican
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-06-01
    End date: 2011-08-01

Myfortic
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-01
    End date: 2011-06-01



Possible Neoral side effects in 60 year old male

Reported by a physician from France on 2012-03-06

Patient: 60 year old male

Reactions: Hepatic Mass, B-Cell Lymphoma, Mediastinal Mass, Pancytopenia, Pyrexia, Epstein-Barr Virus Infection, Diarrhoea, Graft Versus Host Disease in Skin, Proctitis Herpes, BK Virus Infection, Graft Versus Host Disease in Intestine, Cytomegalovirus Infection, Pseudomembranous Colitis, Clostridial Infection, Decreased Appetite

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Myfortic
    Dosage: 750 mg, tid
    Administration route: Oral
    Start date: 2011-03-01
    End date: 2011-06-01

Certican
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Start date: 2011-06-01

Valganciclovir
    Indication: Cytomegalovirus Infection
    End date: 2011-09-01

Mabthera
    Start date: 2011-07-01

Neoral
    Dosage: 100 mg, unk
    Administration route: Oral
    End date: 2011-06-01

Certican
    Dosage: 0.25 mg, bid
    Administration route: Oral
    Start date: 2011-07-29
    End date: 2011-08-01

Mabcampath
    Start date: 2011-07-29

Mabcampath
    Start date: 2011-08-11

Prograf
    Indication: Graft Versus Host Disease in Skin

Neoral
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2011-03-01

Other drugs received by patient: Granocyte; Vistide



Possible Neoral side effects in 12 year old female

Reported by a consumer/non-health professional from United States on 2012-02-29

Patient: 12 year old female

Reactions: Cytomegalovirus Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral

Other drugs received by patient: Tacrolimus; Azathioprine; Mycophenolate Mofetil



Possible Neoral side effects in male

Reported by a physician from France on 2012-02-28

Patient: male, weighing 72.0 kg (158.4 pounds)

Reactions: Impaired Healing, Hypercreatininaemia, Pancytopenia, Cytomegalovirus Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
    Dosage: 500 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-09-19
    End date: 2011-11-19

RAD 666 / RAD 001a
    Dosage: 1.5 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-09-24
    End date: 2011-10-03

Neoral
    Dosage: 750 + 150mg
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-10-07

Mycophenolate Mofetil (Cellcept)
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2011-11-26

Prednisone TAB
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2011-09-25



Possible Neoral side effects in 43 year old male

Reported by a physician from Japan on 2012-02-27

Patient: 43 year old male

Reactions: Cellulitis, Arthralgia, Food Poisoning, Dehydration, Cytomegalovirus Infection, Pyrexia, Arthritis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neoral
    Dosage: 250 mg, unk
    Administration route: Oral
    Start date: 2009-10-23

Mycophenolate Mofetil (Cellcept)
    Dosage: 1000 mg, unk
    Administration route: Oral
    Start date: 2009-09-30

Prednisolone
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2009-09-12
    End date: 2009-09-18

Neoral
    Dosage: 500 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-08-23
    End date: 2009-09-01

Neoral
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2010-10-05

Sandimmune
    Dosage: unk ukn, unk
    Indication: Renal Transplant
    Start date: 2009-09-02

Prednisolone
    Dosage: 40 mg, unk
    Start date: 2009-09-06
    End date: 2009-09-08

Prednisolone
    Dosage: 30 mg, unk
    Administration route: Oral
    Start date: 2009-09-09
    End date: 2009-09-11

Prednisolone
    Dosage: 5 mg, unk
    Administration route: Oral
    Start date: 2009-10-02

Neoral
    Dosage: 350 mg, unk
    Administration route: Oral
    Start date: 2009-10-06

Prednisolone
    Dosage: 50 mg, unk
    Administration route: Oral
    Start date: 2009-09-02
    End date: 2009-09-05

Neoral
    Dosage: 500 mg, unk
    Administration route: Oral
    Start date: 2009-09-03

Neoral
    Dosage: 300 mg, unk
    Administration route: Oral
    Start date: 2009-10-13

Mycophenolate Mofetil (Cellcept)
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-08-05

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Start date: 2009-09-19
    End date: 2009-10-01

Neoral
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2009-09-11

Mycophenolate Mofetil (Cellcept)
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2009-09-03
    End date: 2009-09-29

Prednisolone
    Dosage: 10 mg, unk
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2009-08-28
    End date: 2009-09-01

Other drugs received by patient: Valganciclovir; Tamiflu; Simulect; Simulect; Methylprednisolone Sodium Succinate; Rituxan



Possible Neoral side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-24

Patient: 69 year old female

Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Lactic Acidosis, Pyrexia, Liver Disorder, Epstein-Barr Virus Infection, Multi-Organ Failure, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
    Dosage: 3.5 mg/kg for five days
    Indication: Aplastic Anaemia
    Start date: 2010-09-15

Foscavir
    Dosage: unk ukn, unk

Neoral
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2010-05-01

Other drugs received by patient: Neupogen; Blood and Related Products; Primobolan-Depot INJ



Possible Neoral side effects in 69 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21

Patient: 69 year old female

Reactions: Jaundice, Respiratory Disorder, Renal Disorder, Anaemia, Stenotrophomonas Infection, Pyrexia, Lactic Acidosis, Liver Disorder, Multi-Organ Failure, Epstein-Barr Virus Infection, Hepatomegaly, Cytomegalovirus Infection, Diffuse Large B-Cell Lymphoma, Lymphangiopathy

Adverse event resulted in: death

Drug(s) suspected as cause:
Anti-Thymocyte Globulin Equine NOS
    Dosage: 3.5 mg/kg for five days
    Indication: Aplastic Anaemia
    Start date: 2010-09-15

Foscavir
    Dosage: unk ukn, unk

Neoral
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Aplastic Anaemia
    Start date: 2010-05-01

Other drugs received by patient: Primobolan-Depot INJ; Blood and Related Products; Neupogen



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017